Efficient wound healing matters – not only for your patients, but your standard of care. Delayed healing and complications can result in patient discomfort and significant care burdens, impacting clinical outcomes.
40% of wounds are infected or critically colonised¹.
Hard-to-heal wounds can result in pain, morbidity, prolonged treatment and in some cases major reconstructive surgery².
Chronic wounds are associated with reduced quality of life, mobility and mental wellbeing for both patients and caregivers³.
Wounds may be susceptible to contamination or the development of bioburden – key contributors to complications like infection, inflammation, and delayed healing. 3M™ Veraflo™ Therapy combines vacuum assisted drainage with automated instillation of a topical wound solution to help reduce bioburden through repeated cleansing cycles.
Topical wound solutions are instilled in the wound to help dilute and solubilise infectious material⁴.
Negative pressure helps to remove solubilised wound debris and infectious materials, lowering bioburden⁵.
Veraflo Therapy promotes tissue formation and perfusion to prepare the wound for closure⁶.
3M™ Veraflo™ Therapy may be used in wounds with the following characteristics⁷:
A systematic review of comparative studies and meta-analysis revealed that Veraflo Therapy had a significant effect on clinical outcomes compared to standard of care, including 3M™ V.A.C.® Therapy⁸.
Explore clinical cases of Veraflo Therapy used across various wound types. Plus, view results from a recently published meta-analysis of 13 studies and 720 patients.
1. September 2014 Survey, N = 240, Surgeons, Podiatrists, WOCNs and PT
2. Agarwal P, Rajeev K, Sharma D. Vacuum assisted closure (VAC)/negative pressure wound therapy (NPWT) for difficult wounds: A review. Journal of Clinical Orthopaedics and Trauma 2019; doi: https://doi.org/10.1016/j.jcot.2019.06.015
3. Goh OQ, Ganesan G, Graves N, Ng YZ, Harding K, Tan KB. Incidence of chronic wounds in Singapore, a multiethnic Asian country, between 2000 and 2017: a retrospective cohort study using a nationwide claims database. BMJ Open 2020;10:e039411. doi:10.1136/bmjopen-2020-039411
4. Bjarnsholt T, Eberlein T, Malone M, Schultz G. Management of wound biofilm made easy. London: Wounds International 2017; 8(2).
5. Teot L, Boissiere F, Fluieraru S. Novel foam dressing using negative pressure wound therapy with instillation to remove thick exudate. Int Wound J. 2017 Oct;14(5):842-848.
6. Brinkert D, Mazen A, Naud M, Maire N, Trial C, Teot L. Negative pressure wound therapy with saline instillation: 131 patient case series. Int Wound J. 2013 Dec;10 Suppl 1:56-60
7. Kim PJ Attinger, CE, Constantine T, et al. Negative pressure wound therapy with instillation: International consensus guidelines update. Int Wound J. 2019; 1–13.
8. Gabriel, Allen MD, FACS; Camardo, Mark MS; O’Rorke, Erin BS; Gold, Rebecca BS; Kim, Paul J. DPM, MS, FACFAS Effects of Negative-Pressure Wound Therapy With Instillation versus Standard of Care in Multiple Wound Types: Systematic Literature Review and Meta-Analysis, Plastic and Reconstructive Surgery: January 2021 - Volume 147 - Issue 1S-1 - p 68S-76S doi: 10.1097/PRS.0000000000007614.
9. Camardo, Mark. “Veraflo Meta-Analysis Standardized and Non-Standardized Means.”, 3M Internal Report, San Antonio, Texas, 2020.